home / stock / met / met articles
MetLife (NYSE: MET) came out with quarterly earnings of $1.83 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $1...
A negative sentiment might linger on Wall Street on Wednesday, as evidenced by stock futures, after Advanced Micro Devices, Inc.‘s (NASD...
Corporate earnings came to the market’s rescue in the past week, helping to overcome rate fears. As we look ahead to the unfolding week, it r...
The past week’s earnings were bordering on the negative, impacting trader sentiment, and the focus now shifts to the unfolding week that woul...
Goldman Sachs analyst Alex Scott changed the rating on several insurance stocks, expecting a mixed insurance industry environment in 2024, wit...
In the current session, MetLife Inc. (NYSE:MET) is trading at $60.21, after a 1.81% drop. Over the past month, the stock decreased by 4.34%, and in...
Thursday witnessed a widespread rally across the spectrum of risk markets, with both equities and commodities surging in response to a slew of econ...
Jefferies raised the price target for MetLife, Inc. (NYSE: MET) from $58 to $72. Jefferies analyst Suneet Kamath upgraded the stock from Hold to...
News, Short Squeeze, Breakout and More Instantly...
MetLife (NYSE: MET) came out with quarterly earnings of $1.83 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $1...
A negative sentiment might linger on Wall Street on Wednesday, as evidenced by stock futures, after Advanced Micro Devices, Inc.‘s (NASD...
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...